CIK 1114220

KERYX BIOPHARMACEUTICALS INC

EDGAR filings

Customers

3 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Mar 31, 2018

10-Q filed 2018-05-10

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 3

Companies KERYX BIOPHARMACEUTICALS INC discloses as major customers, as a share of KERYX BIOPHARMACEUTICALS INC revenue. 3 active, 0 lapsed.

Company	% of KERYX BIOPHARMACEUTICALS INC revenue	Est. revenue	Period	Trend	Status	Source
CAH Distributor CARDINAL HEALTH INC	Named	—	3M 2018-03-31	+4.0pp	Active	10-Q 2018-05-10
Cardinal Health, Inc. 20 % 32 % 10-Q filed 2018-05-10 Period 3M 2018-01-01 to 2018-03-31Accession 0001114220-18-000050 Cardinal Health, Inc. 15 % 11 % 10-K filed 2018-02-21 Period FY 2017-01-01 to 2017-12-31 (15%), FY 2016-01-01 to 2016-12-31 (11%)Accession 0001114220-18-000029 Cardinal Health, Inc. 18 % 11 % 10-Q filed 2017-05-04 Period 3M 2017-01-01 to 2017-03-31Accession 0001114220-17-000010 Cardinal Health, Inc. 19 % 24 % 10-Q filed 2016-04-28 Period 3M 2016-01-01 to 2016-03-31Accession 0001193125-16-563667 Cardinal Health, Inc. 11 % 24 % 10-K filed 2018-02-21 Period FY 2015-01-01 to 2015-12-31 (24%)Accession 0001114220-18-000029 Cardinal Health, Inc. 24 % 31 % 10-K filed 2016-02-26 Period FY 2014-01-01 to 2014-12-31Accession 0001193125-16-481950
DVA DAVITA INC.	Named	—	3M 2018-03-31	+8.0pp	Active	10-Q 2018-05-10
DaVita Rx 13 % — % 10-Q filed 2018-05-10 Period 3M 2018-01-01 to 2018-03-31Accession 0001114220-18-000050 DaVita Rx 18 % 10 % 10-K filed 2018-02-21 Period FY 2017-01-01 to 2017-12-31 (18%), FY 2016-01-01 to 2016-12-31 (10%)Accession 0001114220-18-000029 Davita Rx 17 % 10 % 10-Q filed 2017-05-04 Period 3M 2017-01-01 to 2017-03-31Accession 0001114220-17-000010 Davita Rx 24 % 19 % 10-Q filed 2016-04-28 Period 3M 2016-01-01 to 2016-03-31Accession 0001193125-16-563667 DaVita Rx 10 % 19 % 10-K filed 2018-02-21 Period FY 2015-01-01 to 2015-12-31 (19%)Accession 0001114220-18-000029 Davita Rx 19 % 11 % 10-K filed 2016-02-26 Period FY 2014-01-01 to 2014-12-31Accession 0001193125-16-481950
MCK Distributor MCKESSON CORP	Named	—	3M 2018-03-31	−12.0pp	Active	10-Q 2018-05-10
McKesson Corporation 19 % 21 % 10-Q filed 2018-05-10 Period 3M 2018-01-01 to 2018-03-31Accession 0001114220-18-000050 McKesson Corporation 19 % 31 % 10-K filed 2018-02-21 Period FY 2017-01-01 to 2017-12-31 (19%), FY 2016-01-01 to 2016-12-31 (31%)Accession 0001114220-18-000029 McKesson Corporation 23 % 31 % 10-Q filed 2017-05-04 Period 3M 2017-01-01 to 2017-03-31Accession 0001114220-17-000010 McKesson Corporation 21 % 23 % 10-Q filed 2016-04-28 Period 3M 2016-01-01 to 2016-03-31Accession 0001193125-16-563667 McKesson Corporation 31 % 23 % 10-K filed 2018-02-21 Period FY 2015-01-01 to 2015-12-31 (23%)Accession 0001114220-18-000029 McKesson Corporation 23 % 30 % 10-K filed 2016-02-26 Period FY 2014-01-01 to 2014-12-31Accession 0001193125-16-481950

Alerts are coming

Get an email when KERYX BIOPHARMACEUTICALS INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.